Market closed
PAVmed/$PAVM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About PAVmed
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Ticker
$PAVM
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
39
Website
PAVmed Metrics
BasicAdvanced
$12M
1.45
$0.50
1.19
-
Price and volume
Market cap
$12M
Beta
1.19
52-week high
$1.68
52-week low
$0.55
Average daily volume
153K
Financial strength
Current ratio
0.061
Quick ratio
0.044
Long term debt to equity
-31.949
Total debt to equity
-453.007
Interest coverage (TTM)
-988.60%
Management effectiveness
Return on assets (TTM)
-87.19%
Return on equity (TTM)
-183.10%
Valuation
Price to earnings (TTM)
1.452
Price to revenue (TTM)
2.326
Price to book
-1.39
Price to tangible book (TTM)
-1.39
Price to free cash flow (TTM)
-0.209
Growth
Revenue change (TTM)
22.15%
Earnings per share change (TTM)
-105.41%
3-year revenue growth (CAGR)
81.61%
3-year earnings per share growth (CAGR)
-63.00%
What the Analysts think about PAVmed
Analyst Ratings
Majority rating from 4 analysts.
PAVmed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for PAVmed stock?
PAVmed (PAVM) has a market cap of $12M as of April 16, 2025.
What is the P/E ratio for PAVmed stock?
The price to earnings (P/E) ratio for PAVmed (PAVM) stock is 1.45 as of April 16, 2025.
Does PAVmed stock pay dividends?
No, PAVmed (PAVM) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next PAVmed dividend payment date?
PAVmed (PAVM) stock does not pay dividends to its shareholders.
What is the beta indicator for PAVmed?
PAVmed (PAVM) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.